Automated Flow Synthesis of Peptide-PNA Conjugates

被引:23
作者
Li, Chengxi [1 ]
Callahan, Alex J. [1 ]
Phadke, Kruttika S. [2 ]
Bellaire, Bryan [2 ]
Farquhar, Charlotte E. [1 ]
Zhang, Genwei [1 ]
Schissel, Carly K. [1 ]
Mijalis, Alexander J. [1 ]
Hartrampf, Nina [1 ,3 ]
Loas, Andrei [1 ]
Verhoeven, David E. [2 ]
Pentelute, Bradley L. [1 ,4 ,5 ,6 ]
机构
[1] MIT, Dept Chem, Cambridge, MA 02139 USA
[2] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA
[3] Univ Zurich, Dept Chem, Wintherthurerstr 190, CH-8057 Zurich, Switzerland
[4] MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA
[5] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA
[6] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
基金
美国国家科学基金会;
关键词
ANTISENSE MORPHOLINO-OLIGOMERS; NUCLEIC-ACIDS; OLIGONUCLEOTIDES; CELLS;
D O I
10.1021/acscentsci.1c01019
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Antisense peptide nucleic acids (PNAs) have yet to translate to the clinic because of poor cellular uptake, limited solubility, and rapid elimination. Cell-penetrating peptides (CPPs) covalently attached to PNAs may facilitate clinical development by improving uptake into cells. We report an efficient technology that utilizes a fully automated fast -flow instrument to manufacture CPP-conjugated PNAs (PPNAs) in a single shot. The machine is rapid, with each amide bond being formed in 10 s. Anti-IVS2-654 PPNA synthesized with this instrument presented threefold activity compared to transfected PNA in a splice-correction assay. We demonstrated the utility of this approach by chemically synthesizing eight anti-SARS-CoV-2 PPNAs in 1 day. A PPNA targeting the 5 ' untranslated region of SARS-CoV-2 genomic RNA reduced the viral titer by over 95% in a live virus infection assay (IC50 = 0.8 mu M). Our technology can deliver PPNA candidates to further investigate their potential as antiviral agents.
引用
收藏
页码:205 / 213
页数:9
相关论文
共 47 条
[1]   Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication [J].
Ahn, Dae-Gyun ;
Lee, Wooseong ;
Choi, Jin-Kyu ;
Kim, Seong-Jun ;
Plant, Ewan P. ;
Almazan, Fernando ;
Taylor, Deborah R. ;
Enjuanes, Luis ;
Oh, Jong-Won .
ANTIVIRAL RESEARCH, 2011, 91 (01) :1-10
[2]   A peptide nucleic acid targeting nuclear RAD51 sensitizes multiple myeloma cells to melphalan treatment [J].
Alagpulinsa, David Abasiwani ;
Yaccoby, Shmuel ;
Ayyadevara, Srinivas ;
Reis, Robert Joseph Shmookler .
CANCER BIOLOGY & THERAPY, 2015, 16 (06) :976-986
[3]  
Braasch D., 2002, Curr. Prot. Nucleic Acid Chem, V9, P4, DOI DOI 10.1002/0471142700.NC0411S09
[4]   Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models [J].
Burrer, Renaud ;
Neuman, Benjamin W. ;
Ting, Joey P. C. ;
Stein, David A. ;
Moulton, Hong M. ;
Iversen, Patrick L. ;
Kuhn, Peter ;
Buchmeier, Michael J. .
JOURNAL OF VIROLOGY, 2007, 81 (11) :5637-5648
[5]   STABILITY OF PEPTIDE NUCLEIC-ACIDS IN HUMAN SERUM AND CELLULAR-EXTRACTS [J].
DEMIDOV, VV ;
POTAMAN, VN ;
FRANKKAMENETSKII, MD ;
EGHOLM, M ;
BUCHARD, O ;
SONNICHSEN, SH ;
NIELSEN, PE .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (06) :1310-1313
[6]   Viltolarsen: First Approval [J].
Dhillon, Sohita .
DRUGS, 2020, 80 (10) :1027-1031
[7]   PNA HYBRIDIZES TO COMPLEMENTARY OLIGONUCLEOTIDES OBEYING THE WATSON-CRICK HYDROGEN-BONDING RULES [J].
EGHOLM, M ;
BUCHARDT, O ;
CHRISTENSEN, L ;
BEHRENS, C ;
FREIER, SM ;
DRIVER, DA ;
BERG, RH ;
KIM, SK ;
NORDEN, B ;
NIELSEN, PE .
NATURE, 1993, 365 (6446) :566-568
[8]   PEPTIDE NUCLEIC-ACIDS (PNA) - OLIGONUCLEOTIDE ANALOGS WITH AN ACHIRAL PEPTIDE BACKBONE [J].
EGHOLM, M ;
BUCHARDT, O ;
NIELSEN, PE ;
BERG, RH .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (05) :1895-1897
[9]   Chimeras of Cell-Penetrating Peptides Demonstrate Synergistic Improvement in Antisense Efficacy [J].
Fadzen, Colin M. ;
Holden, Rebecca L. ;
Wolfe, Justin M. ;
Choo, Zi-Ning ;
Schissel, Carly K. ;
Yao, Monica ;
Hanson, Gunnar J. ;
Pentelute, Bradley L. .
BIOCHEMISTRY, 2019, 58 (38) :3980-3989
[10]   Cell-Penetrating Peptide Conjugates of Steric Blocking Oligonucleotides as Therapeutics for Neuromuscular Diseases from a Historical Perspective to Current Prospects of Treatment [J].
Gait, Michael J. ;
Arzumanov, Andrey A. ;
McClorey, Graham ;
Godfrey, Caroline ;
Betts, Corinne ;
Hammond, Suzan ;
Wood, Matthew J. A. .
NUCLEIC ACID THERAPEUTICS, 2019, 29 (01) :1-12